Is Taiko Pharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Taiko Pharmaceutical pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Wednesday 29th of December 2021 were paid JPY13 per share. Over the last 18 times between 2009 and 2021, Taiko Pharmaceutical has paid JPY150 with an average of JPY8.33 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Taiko Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was JPY780.67, you would have made a loss of JPY-371.67 per share or -47.61%
Yes, the average daily trading liquidity for Taiko Pharmaceutical is JPY240 785 thousand. You should therefore be able to get in and out of your positions relatively fast.
Taiko Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Taiko Pharmaceutical to be high [0.75 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.